Retirement Systems of Alabama reduced its position in CME Group Inc. (NASDAQ:CME) by 0.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 172,643 shares of the company’s stock after selling 162 shares during the period. Retirement Systems of Alabama’s holdings in CME Group were worth $16,815,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in CME. Parametrica Management Ltd bought a new stake in CME Group during the second quarter valued at approximately $212,000. Franklin Resources Inc. bought a new stake in CME Group during the first quarter valued at approximately $222,000. Financial Architects Inc bought a new stake in CME Group during the second quarter valued at approximately $234,000. EFG Asset Management Americas Corp. bought a new stake in CME Group during the first quarter valued at approximately $244,000. Finally, Windward Capital Management Co. CA boosted its stake in CME Group by 1.0% in the second quarter. Windward Capital Management Co. CA now owns 2,626 shares of the company’s stock valued at $256,000 after buying an additional 25 shares in the last quarter. 80.29% of the stock is currently owned by institutional investors and hedge funds.
CME Group Inc. (NASDAQ:CME) traded down 0.19% during trading on Friday, hitting $104.52. 2,069,677 shares of the company’s stock were exchanged. CME Group Inc. has a 12-month low of $81.87 and a 12-month high of $110.35. The company’s 50-day moving average price is $106.83 and its 200 day moving average price is $99.14. The firm has a market cap of $35.42 billion, a price-to-earnings ratio of 26.39 and a beta of 0.85.
CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, July 28th. The company reported $1.14 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.11 by $0.03. The business earned $906 million during the quarter, compared to analyst estimates of $897.84 million. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The company’s quarterly revenue was up 10.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.95 earnings per share. Equities analysts forecast that CME Group Inc. will post $4.44 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, September 26th. Investors of record on Friday, September 9th were given a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 2.30%. The ex-dividend date was Wednesday, September 7th. CME Group’s payout ratio is currently 60.61%.
A number of research analysts recently issued reports on the stock. Deutsche Bank AG lifted their price target on shares of CME Group from $110.00 to $111.00 and gave the company a “buy” rating in a research report on Friday, July 29th. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $99.00 to $106.00 and gave the stock an “overweight” rating in a report on Friday, July 29th. Barclays PLC decreased their target price on shares of CME Group from $100.00 to $99.00 and set an “equal weight” rating for the company in a report on Friday, July 29th. Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Thursday, June 30th. Finally, Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $99.00 to $103.00 and gave the stock a “market perform” rating in a report on Friday, July 29th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $102.89.
In other CME Group news, Director James E. Oliff sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, July 15th. The shares were sold at an average price of $102.30, for a total transaction of $102,300.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Phupinder Gill sold 20,080 shares of the firm’s stock in a transaction that occurred on Monday, August 15th. The stock was sold at an average price of $104.54, for a total transaction of $2,099,163.20. Following the transaction, the chief executive officer now directly owns 154,141 shares of the company’s stock, valued at $16,113,900.14. The disclosure for this sale can be found here. 0.61% of the stock is currently owned by corporate insiders.
CME Group Company Profile
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.